首页> 外文期刊>Journal of Pediatric Surgery Case Reports >Giant mediastinal lymphatic malformation in a neonate treated with sclerotherapy
【24h】

Giant mediastinal lymphatic malformation in a neonate treated with sclerotherapy

机译:硬化疗法治疗的新生儿巨大纵隔淋巴畸形

获取原文
           

摘要

Lymphatic malformation or previously known as ‘lymphangioma’are well-recognized congenital pathologies among the pediatric-agegroup, usually presenting before the age of 5 years [1,2], with an incidence of approximately 1/6000 live births [3]. The presentation andtreatment vary according to the site and size, which can occur in anypart of the body, usually in the head and neck or axillary areas [1,4].Less than 1% of all lymphatic malformation are isolated in the mediastinum [2,5,6], and more than 90% are diagnosed within the first 2years of life [2]. This report describes a case of a giant congenitalposterior thoracic lymphatic malformation and its progress after treatment with sclerotherapy injection using bleomycin from birth till discharge.
机译:淋巴畸形或以前称为“淋巴管瘤”是小儿年龄组中公认的先天性病变,通常在5岁之前出现[1,2],其发病率约为1/6000活产[3]。表现和治疗方法根据部位和大小的不同而不同,它可以发生在身体的任何部位,通常在头,颈或腋窝区域[1,4]。不到1%的淋巴畸形是在纵隔中分离出来的[2]。 ,5,6],并且在生命的头2年内诊断出超过90%[2]。该报告描述了一例先天性后胸巨大淋巴管畸形及其从出生至出院使用博莱霉素的硬化疗法注射治疗后的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号